NorthRock Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-19,055
| Closed | -$16.9K | – | 363 |
|
|
2022
Q4 | $16.9K | Hold |
19,055
| – | – | ﹤0.01% | 341 |
|
|
2022
Q3 | $30K | Hold |
19,055
| – | – | ﹤0.01% | 298 |
|
|
2022
Q2 | $38K | Hold |
19,055
| – | – | ﹤0.01% | 301 |
|
|
2022
Q1 | $44K | Sell |
19,055
-5,945
| -24% | -$13.7K | ﹤0.01% | 333 |
|
|
2021
Q4 | $116K | Buy |
+25,000
| New | +$116K | 0.01% | 324 |
|